COVID-19 (Coronavirus) Clinical Trials at UMMC

Researchers at UMMC are committed to discovering new and innovative ways to prevent and treat the diseases that affect our daily lives, with the ultimate goal to improve the well-being of our families, friends, communities and future generations. However, we cannot do it alone. Clinical research studies are vital to the advancement of medicine and our vision to create "a healthier Mississippi."

Browse our ongoing clinical trials below, and use the left-hand filters to narrow your search.

To learn more about our clinical trials and how to participate, click here.


Search Filters Clear

Keywords
Study Categories
3 Total Trials for "Allergy/Asthma/Immunology"
2 Total Trials for "Arthritis/Rheumatology"
111 Total Trials for "Cancer"
23 Total Trials for "COVID-19 (Coronavirus)"
1 Total Trial for "Dermatology/Skin Care"
1 Total Trial for "Developmental Disorders"
12 Total Trials for "Digestive Conditions"
4 Total Trials for "Emergency Medicine"
2 Total Trials for "Endocrinology/Diabetes"
2 Total Trials for "Eyes/Vision"
6 Total Trials for "Genetics"
1 Total Trial for "Hearing"
20 Total Trials for "Heart Health"
10 Total Trials for "Infectious Diseases"
7 Total Trials for "Kidney/Renal Conditions"
1 Total Trial for "Liver Diseases"
20 Total Trials for "Lungs/Breathing"
3 Total Trials for "Men's Health"
11 Total Trials for "Neurosciences"
2 Total Trials for "Orthopaedics"
1 Total Trial for "Palliative Care"
47 Total Trials for "Pediatrics"
3 Total Trials for "Preventive Medicine"
2 Total Trials for "Rehabilitation Services"
1 Total Trial for "Sleep Medicine"
8 Total Trials for "Stroke/Traumatic Brain Injury"
12 Total Trials for "Surgery"
1 Total Trial for "Transplant"
1 Total Trial for "Weight Management"
18 Total Trials for "Women's Health"
Study Locations
Jackson Metro
Grenada
Holmes County
Study Status



Study Type

Biological Sex
Age
Study Phase




Other Criteria

Clinical Trials Displaying Items 1 - 20 of 23

May 03, 2022

AV001-004: Phase 2a multiple-dose escalating study in hospitalized patients with COVID-19 disease

Locations: University Hospital - UMMC
April 18, 2022

NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults

Locations: University Hospital - UMMC
October 15, 2021

Novel Experimental COVID Therapies Affecting Host Response

Locations: University Hospital - UMMC
October 29, 2020

A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsor Hospitalized Patients with COVID-19

Locations: University Hospital - UMMC
October 23, 2020

Randomized Master Protocol for Immune Modulators for Treating COVID-19

Locations: University Hospital - UMMC
October 23, 2020

A Randomized, Double-Blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older

Locations: University Hospital - UMMC
October 22, 2020

A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19

Locations: University Hospital - UMMC
October 22, 2020

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE IIA STUDY OF XXX + STANDARD OF CARE (SOC) VS SOC IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH COVID-19

Locations: University Hospital - UMMC
September 08, 2020

A Phase 2/3 Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of MK-4482 in Hospitalized Participants ≥18 Years of Age with COVID-19

Locations: University Hospital - UMMC
September 08, 2020

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of severe COVID-19

Locations: University Hospital - UMMC
August 17, 2020

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

Locations: University Hospital - UMMC
August 17, 2020

A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with Covid-19

Locations: University Hospital - UMMC
August 11, 2020

A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records

Locations: Jackson Medical Mall - UMMC Clinics, University Hospital - UMMC
July 21, 2020

Trial of Early Antiviral Therapies during Non hospitalized Outpatient Window (TREAT NOW) for COVID-19

Locations: University Hospital - UMMC
June 30, 2020

Bio surveillance to determine Prevalence of SARS-CoV-2 Specific Antibodies in UMMC Employees with Varying Exposure to COVID-19 Patients

Locations: University Hospital - UMMC
June 08, 2020

Creation of a Registry of Pediatric Respiratory Samples and Plasma/Sera to Define Viral Profiles and SARS-CoV2 Seroprevalence in Mississippi Children During the Global SARS-CoV2 (COVID19) Pandemic

Locations: University Hospital - UMMC
April 27, 2020

COVID-19 Biobank (Adult and Pediatric)

Locations: University Hospital - UMMC
April 20, 2020

An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients with Moderate to Severe COVID-19

Locations: University Hospital - UMMC
April 16, 2020

A Phase 1b/2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects with Severe Coronavirus Disease 2019 (COVID-19)

Locations: University Hospital - UMMC
April 16, 2020

An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Relation to COVID 19 (DARE 19)

Locations: University Hospital - UMMC